Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 19150560)

1.

Devices for protecting the rectum during radiation therapy of prostate cancer.

Rossi PJ, Johnstone PA.

J Urol. 2009 Mar;181(3):947-8. doi: 10.1016/j.juro.2008.12.031. Epub 2009 Jan 16. No abstract available.

PMID:
19150560
2.
3.

[Conformal intensity modulated radiation therapy for localized prostate cancer: Toward a new standard].

Azria D, Aillères N, Llacer Moscardo C, Hay MH, Dubois JB, Fenoglietto P.

Cancer Radiother. 2009 Sep;13(5):409-15. doi: 10.1016/j.canrad.2008.12.004. Epub 2009 Feb 25. French.

PMID:
19246230
4.

Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.

Rijkhorst EJ, Lakeman A, Nijkamp J, de Bois J, van Herk M, Lebesque JV, Sonke JJ.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1254-60. doi: 10.1016/j.ijrobp.2009.04.034.

PMID:
19857789
5.

Intensity modulated radiation therapy safe, effective for prostate cancer.

[No authors listed]

Duke Med Health News. 2007 Jan;13(1):10. No abstract available.

PMID:
17299890
6.

[Cervix carcinomas: place of intensity-modulated radiotherapy].

Barillot I.

Cancer Radiother. 2009 Oct;13(6-7):507-10. doi: 10.1016/j.canrad.2009.05.015. Epub 2009 Aug 19. French.

PMID:
19695927
7.

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.

Fonteyne V, De Gersem W, De Neve W, Jacobs F, Lumen N, Vandecasteele K, Villeirs G, De Meerleer G.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1013-20. doi: 10.1016/j.ijrobp.2008.12.047. Epub 2009 Apr 20.

PMID:
19386427
8.

Biodegradable inflatable balloon for reducing radiation adverse effects in prostate cancer.

Levy Y, Paz A, Yosef RB, Corn BW, Vaisman B, Shuhat S, Domb AJ.

J Biomed Mater Res B Appl Biomater. 2009 Nov;91(2):855-67. doi: 10.1002/jbm.b.31467.

PMID:
19582846
9.

A novel device for protecting rectum during prostate cancer irradiation: in vivo data on a large mammal model.

Ben-Yosef R, Paz A, Levy Y, Alani S, Muncher Y, Shohat S, Domb A, Corn B.

J Urol. 2009 Mar;181(3):1401-6. doi: 10.1016/j.juro.2008.11.010. Epub 2009 Jan 20.

PMID:
19157458
10.

Radiation management of prostate cancer.

Glicksman AS.

Med Health R I. 2006 Feb;89(2):74-5. Review. No abstract available.

PMID:
16583666
11.

Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.

Liauw SL, Weichselbaum RR, Rash C, Correa D, Al-Hallaq HA, Pelizzari CA, Jani AB.

Technol Cancer Res Treat. 2009 Jun;8(3):201-6.

PMID:
19445537
12.

[On board imaging with cone beam CBCT kV VARIAN: Montauban's radiation therapy department experience].

Dudouet P, Boutry C, Mounié G, Latorzeff I, Thouveny F, Redon A.

Cancer Radiother. 2009 Sep;13(5):375-83. doi: 10.1016/j.canrad.2009.06.003. Epub 2009 Jul 28. French.

PMID:
19640766
13.

Clinical stage T3 prostate cancer: the added value of three-dimensional conformal/intensity-modulated external-beam radiotherapy.

Bolla M.

Eur Urol. 2008 Jun;53(6):1104-6; discussion 1106-8. doi: 10.1016/j.eururo.2008.02.004. Epub 2008 Feb 20. No abstract available.

PMID:
18295394
14.

Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.

Namiki S, Ishidoya S, Ito A, Tochigi T, Numata I, Narazaki K, Yamada S, Takai Y, Arai Y.

Jpn J Clin Oncol. 2009 Nov;39(11):732-8. doi: 10.1093/jjco/hyp086. Epub 2009 Aug 8.

15.

Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.

Fonteyne V, Villeirs G, Lumen N, De Meerleer G.

Radiother Oncol. 2009 Jul;92(1):42-7. doi: 10.1016/j.radonc.2009.03.013. Epub 2009 Apr 6.

PMID:
19356817
16.

EUS-guided fiducial placement before targeted radiation therapy for prostate cancer.

Yang J, Abdel-Wahab M, Ribeiro A.

Gastrointest Endosc. 2009 Sep;70(3):579-83. doi: 10.1016/j.gie.2009.03.001. Epub 2009 Jun 26.

PMID:
19560140
17.

A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.

Hermesse J, Biver S, Jansen N, Lenaerts E, De Patoul N, Vynckier S, Coucke P, Scalliet P, Nickers P.

Strahlenther Onkol. 2009 Nov;185(11):736-42. doi: 10.1007/s00066-009-2009-5. Epub 2009 Nov 10.

PMID:
19899007
18.

Radiotherapy for prostate cancer.

Rutz HP, Lomax AJ.

N Engl J Med. 2007 Jan 18;356(3):308-9; author reply 310-1. No abstract available.

19.

Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).

Ost P, Fonteyne V, De Neve W, De Gersem W, De Wagter C, Vandecasteele K, Duprez F, De Meerleer G.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1286; author reply 1287. doi: 10.1016/j.ijrobp.2008.12.008. No abstract available.

PMID:
19251105
20.

Monte Carlo dose verification of prostate patients treated with simultaneous integrated boost intensity modulated radiation therapy.

Dogan N, Mihaylov I, Wu Y, Keall PJ, Siebers JV, Hagan MP.

Radiat Oncol. 2009 Jun 15;4:18. doi: 10.1186/1748-717X-4-18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk